AMGEN at AHA Annual Meeting

Addressing Gaps in Cardiovascular Health

Cardiovascular disease is one of the most significant public health issues in the world. Our commitment to cardiovascular disease remains steadfast, and supporting cross-sector collaborative programs and patient-advocacy initiatives is part of this commitment. A key focus of this work is moving from a reactive healthcare model toward a proactive and innovative public health approach aimed to predict and prevent the impact of serious diseases from occurring. Together, we are employing and testing not just one approach but a range of innovative initiatives to help improve patient outcomes and address population health.

ASCVD: atherosclerotic cardiovascular disease, LDL: low-density lipoprotein, LDL-C: low-density lipoprotein-cholesterol